Through the construction of genetically modified mice and in vitro experiments, we demonstrated that deletion of Nrp1 or simultaneous deletion of the genes encoding the TGF-β receptor and Nrp1 delay the progression of renal fibrosis and inhibit Smad3 expression. The gene discussed is SMAD3; the disease is renal fibrosis.